Firefly Neuroscience (AIFF) Liabilities and Shareholders Equity (2010 - 2026)

Firefly Neuroscience's Liabilities and Shareholders Equity history runs 16 years deep, the most recent figure standing at $10.9 million for Q1 2026.

• On a quarterly basis, Liabilities and Shareholders Equity fell 11.75% year-over-year to $10.9 million in Q1 2026; TTM through Mar 2026 was $48.7 million, a 90.47% increase from a year earlier, with the FY2025 full-year figure at $10.5 million, up 127.71% from the prior year.
• Liabilities and Shareholders Equity grew to $10.9 million in Q1 2026 per AIFF's latest filing, from $10.5 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $21.2 million in Q1 2022 and bottomed at $2.6 million in Q4 2023.
• The 5-year median for Liabilities and Shareholders Equity is $8.0 million (2022), against an average of $9.7 million.
• Across the five-year window, Liabilities and Shareholders Equity plunged 69.02% in 2023 and jumped 351.31% in 2025, its largest moves.
• Year by year, Liabilities and Shareholders Equity stood at $8.0 million in 2022, then plunged by 66.91% to $2.6 million in 2023, then soared by 74.21% to $4.6 million in 2024, then soared by 127.71% to $10.5 million in 2025, then grew by 4.13% to $10.9 million in 2026.
• Per Business Quant, the three latest AIFF Liabilities and Shareholders Equity figures stand at $10.9 million (Q1 2026), $10.5 million (Q4 2025), and $12.4 million (Q3 2025).